{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T14:53:39Z","timestamp":1776092019866,"version":"3.50.1"},"reference-count":52,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2004,10,19]],"date-time":"2004-10-19T00:00:00Z","timestamp":1098144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2004,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Published case reports on complex visual hallucinations (CVH) occurring during antidepressant (AD) treatment were reviewed. Thirteen cases of CVH associated with SSRI treatment, 16 cases during tricyclic drug treatment and seven cases with other AD drug treatments were found.<\/jats:p><jats:p>Nine patients were taking concomitant drugs while on therapy with SSRIs and four had a neurological disease in addition to depression. The cholinergic impoverishment occurring in dementia states or during concomitant therapy with anticholinergic drugs could increase the sensitivity to serotonergic agonists, triggering the manifestation of CVH.<\/jats:p><jats:p>During tricyclic drug treatment, half of the reports were of hypnopompic or hypnagogic hallucinations and this can be associated with the effects of tricyclics (TCA) on sleep architecture. It is likely that the potent anticholinergic effect of amitriptyline was potentiated in a situation of a rapidly changing state of consciousness.<\/jats:p><jats:p>In general, the review supports the view that an imbalance between serotonin and acetylcholine systems is at the root of AD\u2010induced CVH, with a profile defined by a cholinergic hypoactivity and a serotonergic hyperactivity.<\/jats:p><jats:p>Caution is needed when administering a combination of serotonergic and anticholinergic AD in the treatment of the demented population and in other already compromised patients because there is a risk of precipitating CVH. Copyright \u00a9 2004 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hup.640","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T09:33:15Z","timestamp":1098264795000},"page":"577-584","source":"Crossref","is-referenced-by-count":39,"title":["Factors associated with complex visual hallucinations during antidepressant treatment"],"prefix":"10.1002","volume":"19","author":[{"given":"Iacopo","family":"Cancelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Marcon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Balestrieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,19]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"140","article-title":"Visual hallucinations after combining fluoxetine and dextromethorphan","volume":"149","author":"Achamallah NS","year":"1992","journal-title":"Am J Psychiatry"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.npp.1395318"},{"key":"e_1_2_1_4_1","volume-title":"AHFS Drugs Information","year":"2004"},{"key":"e_1_2_1_5_1","first-page":"53","article-title":"Organic mental disorders associated with bupropion in three patients","volume":"53","author":"Ames D","year":"1992","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200108000-00020"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.143.9.1088"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/0010-440X(82)90052-9"},{"key":"e_1_2_1_9_1","volume-title":"Psychotropic Drug Directory 2003\/04","author":"Bazire S","year":"2004"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/91.2.321"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881103017001716"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199812000-00012"},{"key":"e_1_2_1_13_1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1177\/070674375900401S16","article-title":"The use of tofranil in the aged","volume":"4","author":"Cameron DE","year":"1959","journal-title":"Can Psychiatr Assoc J"},{"key":"e_1_2_1_14_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/070674375900401S09","article-title":"Efficacy of tofranil in the treatment of various types of depression: a comparison with other antidepressant drugs","volume":"4","author":"Delay J","year":"1959","journal-title":"Can Psychiatr Assoc J"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199005010-00002"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/15563659809028939"},{"key":"e_1_2_1_17_1","first-page":"198","article-title":"Visual and auditory hallucinations with association of bupropion and valproate","volume":"45","author":"Filteau MJ","year":"2000","journal-title":"Can J Psychiatry"},{"key":"e_1_2_1_18_1","first-page":"574","article-title":"Hallucinations caused by paroxetine taken together with a levodopa\u2010carbidopa preparation","volume":"146","author":"Freijzer PL","year":"2002","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.151.3.450a"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(84)90436-3"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0210d"},{"key":"e_1_2_1_22_1","first-page":"22","article-title":"Treatment of depressive states in old age with imipramine","volume":"32","author":"Hanson LC","year":"1961","journal-title":"Nervenarzt"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1980.tb00622.x"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/7.9.1507"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2000.101006476.x"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.198.1.199"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1990.01070050097040"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.121.6.611"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1996.01100130045007"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.121.9.911"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.153.10.1365b"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1819.2003.01163.x"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.150.11.1750a"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/070674375800300401"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1557(199907)8:4<267::AID-PDS423>3.0.CO;2-K"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/121.10.1819"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v65n0322f"},{"key":"e_1_2_1_38_1","first-page":"383","volume-title":"Molecular Neuropharmacology: A Foundation for Clinical Neuroscience","author":"Nestler EJ","year":"2001"},{"key":"e_1_2_1_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/00048678209161271"},{"key":"e_1_2_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(95)00195-M"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-004-0041-4"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-2236(98)01361-7"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1991.tb00217.x"},{"key":"e_1_2_1_44_1","first-page":"A 374","article-title":"Comparison of fluvoxamine versus amitriptyline for the treatment of depression in Parkinson's disease","volume":"46","author":"Rabey JM","year":"1996","journal-title":"Neurology"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122009926"},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-198802000-00037"},{"key":"e_1_2_1_47_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.136.2.219"},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200010000-00014"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)00135-P"},{"key":"e_1_2_1_50_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-199920030-00007"},{"key":"e_1_2_1_51_1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.5694\/j.1326-5377.1960.tb78367.x","article-title":"Tofranil a new antidepressant drug","volume":"47","author":"Stoller A","year":"1960","journal-title":"Med J Aust"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1999.tb07246.x"},{"key":"e_1_2_1_53_1","first-page":"318","article-title":"Visual hallucinations and amnesia associated with the use of zolpidem","volume":"34","author":"Van Puijenbroek EP","year":"1996","journal-title":"Int J Clin Pharmacol Ther"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.640","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T21:47:20Z","timestamp":1700171240000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,19]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["10.1002\/hup.640"],"URL":"https:\/\/doi.org\/10.1002\/hup.640","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,19]]}}}